Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial.

CONCLUSIONS: Repeated oral administration of 2-HOBA was found to be safe and well-tolerated. These results support continued development of 2-HOBA as a nutritional supplement. TRIAL REGISTRATION: Studies are registered at ClinicalTrials.gov (NCT03555682 Registered 13 June 2018, NCT03554096 Registered 12 June 18). PMID: 31907026 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31907026?dopt=Abstract

Source: BMC Pharmacology and Toxicology - January 8, 2020 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research